Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
life sciences
3
×
national blog main
oncology
3
×
alder biopharmaceuticals
american society of clinical oncology
amgen
antibody conjugates
asco
astrazeneca
bolt biotherapeutics
boston
boston blog main
boston top stories
bristol-myers squibb
celgene
deals
deerfield management
edithe perez
euclidean capital
funding
her2
immunotherapy
johnson & johnson innovation - jjdc
jp morgan healthcare conference
lung cancer
mirati therapeutics
national top stories
niraparib
novartis venture fund
olaparib
osage university partners
parp inhibitors
randy schatzman
ribon therapeutics
san diego
san diego blog main
san diego top stories
san francisco
What
cancer
3
×
approach
drugs
funding
adds
advance
ahead
antibody
bio
bio’s
blocking
bolt
breast
ceo
class
conjugate
dna
drug
generation
immune
immunotherapy
inhibitor
lead
mechanism
million
mirati
months
new
novel
offering
ovarian
parp
phase
pills
plans
public
pursue
raise
raises
randy
Language
unset
Current search:
cancer
×
oncology
×
" life sciences "
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}